Introduction
============

Strain Prévot Te3^T^ (= DSM 2008 = ATCC 10790 = JCM 12972) is the type strain of the species *Veillonella parvula* and was first described in 1898 by Veillon and Zuber \[[@r1]\] as "*Staphylococcus parvulus*" before it was renamed as *Veillonella parvula* by Prévot in 1933 \[[@r2]\]. Although it is a Gram-negative organism harboring lipopolysaccharide \[[@r3]\] it is more closely related to Gram-positive species like *Sporomusa*, *Megasphaera* or *Selenomonas*. Together, they share the unusual presence of cadaverine and putrescine in their cell walls \[[@r4]\]. The genus *Veillonella* comprises 11 species (status July 2009) which are all known to inhabit the oral cavity and the gastrointestinal tract of homeothermic vertebrates. Six of the species, among them *V. parvula*, have been isolated from man, the others are typical for rodents \[[@r5]\]. In general, veillonellae are harmless inhabitants of most body cavities, however, occasionally they can participate in multispecies infections at diverse body sites and in rare cases cause severe infections also as pure cultures \[[@r6]\].

Here we present a summary classification and a set of features for *V. parvula* Te3^T^, together with the description of the complete genomic sequencing and annotation.

Classification and features
===========================

The natural habitat is human dental plaque and *V. parvula* can amount to up to 98% of the cultivable veillonellae in healthy subgingival sites \[[@r7]\]. Additionally, veillonellae are common inhabitants of the gastrointestinal tract. Although the other species of the genus *Veillonella* are found in large numbers throughout the oral cavity, *V. parvula* is the only species of the genus involved in oral diseases such as gingivitis. It has also been isolated in rare cases of endocarditis, meningitis, discitis \[[@r8]\] or bacteremia as pure culture but more often *V. parvula* is involved in multispecies infections (reviewed in \[[@r6]\]). Medline indexes few cultivated strains with a high degree of 16S rRNA gene sequence similarity to Te3^T^, e.g. DJF_B315 from porcine intestine (EU728725, Hojberg and Jensen, unpublished, 99.9% identity). The other type strains of the genus *Veillonella* vary from 94.1% (*V. ratti*) to 99.2% (*V. dispar*). A vast number of phylotypes with significant 16S rRNA sequence similarity to *V. parvula* were observed from intubated patients \[[@r9]\], carious dentine from advanced caries (AY995757; 99.7% identity), and the human skin microbiome \[[@r10]\]. Curiously, only one sample from a human gut metagenome analysis \[[@r11]\] scored above 96% sequence similarity in screenings of environmental samples (status September 2009).

[Figure 1](#f1){ref-type="fig"} shows the phylogenetic neighborhood of *V. parvula* strain Te3^T^ in a 16S rRNA based tree. The sequences of the four copies of the 16S rRNA gene in the genome differ by up to seven nucleotides, and differ by up to four nucleotides from the previously published sequence generated from ATCC 10790 (AY995767).

![Phylogenetic tree highlighting the position of *V. parvula* strain Te3^T^ relative to all other type strains within the genus *Veillonella*. The tree was inferred from 1,378 aligned characters \[[@r12],[@r13]\] of the 16S rRNA gene sequence under the maximum likelihood criterion \[[@r14]\]. The tree was rooted with the type strains of other genera within the family *Veillonellaceae*. The branches are scaled in terms of the expected number of substitutions per site. Numbers above branches are support values from 1,000 bootstrap replicates if greater than 60%. Lineages with type strain genome sequencing projects registered in GOLD \[[@r15]\] are shown in blue, published genomes in bold.](sigs.521107-f1){#f1}

*V. parvula* is a Gram-negative, non-motile, non-sporeforming, anaerobic coccus (approximately 0.3 to 0.5 µm in diameter) that grows in pairs or short chains ([Table 1](#t1){ref-type="table"} and [Figure 2](#f2){ref-type="fig"}). Veillonellae are characterized by an unusual metabolism using methylmalonyl-CoA decarboxylase to convert the free energy derived from decarboxylation reactions into an electrochemical gradient of sodium ions \[[@r29]\]. They utilize the metabolic end products of co-existing carbohydrate-fermenting bacteria, i.e. lactic acid bacteria in the gastrointestinal tract, and thereby play an important role in a natural microbial food chain \[[@r6]\]. Another characteristic trait of veillonellae is their ability to form intergeneric coaggregates with other bacteria which occur in the same ecological niche \[[@r30]\]. Although *Veillonella* cannot adhere to surfaces itself, the bacterium is able to attach to specific surface structures present on other cells, often mediated by lectin-carbohydrate interactions \[[@r31]\]. The coaggregation creates a functional community providing nutrients and protection for all participants.

###### Classification and general features of *V. parvula* Te3^T^ according to the MIGS recommendations \[[@r16]\].

  ---------------------------------------------------------------------------------------------------------------------------------------
  **MIGS ID**                     **Property**             **Term**                                               **Evidence code**
  ------------------------------- ------------------------ ------------------------------------------------------ -----------------------
                                  Current classification   Domain *Bacteria*                                      TAS \[[@r17]\]

  Phylum *Firmicutes*             TAS \[[@r18],[@r19]\]                                                           

  Class *Clostridia*              TAS \[[@r18]\]                                                                  

  Order *Clostridiales*           TAS \[[@r20],[@r21]\]                                                           

  Family *Veillonellaceae*        TAS \[[@r22],[@r23]\]                                                           

  Genus *Veillonella*             TAS \[[@r2]\]                                                                   

  Species *Veillonella parvula*   TAS \[[@r2]\]                                                                   

  Type strain Te3                 TAS \[[@r2]\]                                                                   

                                  Gram stain               negative                                               TAS \[[@r1]\]

                                  Cell shape               small cocci                                            TAS \[[@r1]\]

                                  Motility                 nonmotile                                              TAS \[[@r1]\]

                                  Sporulation              nonsporulating                                         TAS \[[@r1]\]

                                  Temperature range        mesophile                                              TAS \[[@r1]\]

                                  Optimum temperature      37°C                                                   TAS \[[@r1]\]

                                  Salinity                 normal                                                 TAS \[[@r1]\]

  MIGS-22                         Oxygen requirement       anaerobic                                              TAS \[[@r1]\]

                                  Carbon source            acid production from lactate and other organic acids   TAS \[[@r24]\]

                                  Energy source            lactate; succinate                                     TAS \[[@r25],[@r26]\]

  MIGS-6                          Habitat                  human gastrointestinal tract                           TAS \[[@r1]\]

  MIGS-15                         Biotic relationship      human pathogen                                         TAS \[[@r1]\]

  MIGS-14                         Pathogenicity            subgingival plaque formation; opportunistic pathogen   TAS \[[@r1]\]

                                  Biosafety level          2                                                      TAS \[[@r27]\]

                                  Isolation                human intestinal tract                                 TAS \[[@r1]\]

  MIGS-4                          Geographic location      unknown, probably France                               TAS \[[@r1]\]

  MIGS-5                          Sample collection time   before 1898                                            TAS \[[@r1]\]

  MIGS-4.1\                       Latitude, Longitude      unknown                                                
  MIGS-4.2                                                                                                        

  MIGS-4.3                        Depth                    not reported                                           

  MIGS-4.4                        Altitude                 not reported                                           
  ---------------------------------------------------------------------------------------------------------------------------------------

Evidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from of the Gene Ontology project \[[@r28]\]. If the evidence code is IDA, then the property was observed for a live isolate by one of the authors or an expert mentioned in the acknowledgements.

![Scanning electron micrograph of *V. parvula* Te3^T^](sigs.521107-f2){#f2}

Strain Te3^T^ produces propionic and acetic acid, carbon dioxide and hydrogen from lactate and other organic acids like pyruvate, malate or fumarate. *V. parvula* cannot grow on succinate as a sole carbon source but can decarboxylate succinate during fermentation of lactate or malate \[[@r25]\]. Veillonellae are unable to use glucose or other carbohydrates for fermentation \[[@r26]\] and they do not possess a functional hexokinase \[[@r24]\]. Nitrate is reduced and arginine dihydrolase is produced.

Veillonellae show resistance to tetracycline (\>25 µg/ml), erythromycin (\>25 µg/ml) gentamicin (\>25 µg/ml) and kanamycin (\>25 µg/ml) and they are susceptible to penicillin G (0.4 µg/ml), cephalotin (1.6 µg/ml) and clindamycin (0.1 µg/ml). Their resistance is intermediate for chloramphenicol (3.1 µg/ml) and lincomycin (6.2 µg/ml) \[[@r32]\].

Chemotaxonomy
-------------

The cell wall of *V. parvula* comprises an outer membrane, clearly demonstrating the presence of lipopolysaccharide \[[@r33]\]. The peptidoglycan of veillonellae is of the A1γ-type with glutamic acid in D configuration, diaminopimelic acid in meso configuration and covalently bound cadaverine or putrescine attached in α-linkage to glutamic acid \[[@r34]\]. As major fatty acids straight-chain saturated C~13:0~ (24%), C~15:0~ (12%) and C~16:0~ (7%) and unsaturated C~16:1~ (5%), C~17:1~ (22%) and C~18:1~ (6%) are synthesized \[[@r35]\]. Another characteristic feature of *V. parvula* is the presence of plasmalogens such as plasmenylethanolamine and plasmenylserine as major constituents of the cytoplasmic membrane. These ether lipids replace phospholipids and play an important role in the regulation of membrane fluidity \[[@r36]\].

Genome sequencing and annotation
================================

Genome project history
----------------------

This organism was selected for sequencing on the basis of its phylogenetic position, and is part of the ***G****enomic* ***E****ncyclopedia of* ***B****acteria and* ***A****rchaea* project. The genome project is deposited in the Genome OnLine Database \[[@r15]\] and the complete genome sequence is deposited in GenBank. Sequencing, finishing and annotation were performed by the DOE Joint Genome Institute (JGI). A summary of the project information is shown in [Table 2](#t2){ref-type="table"}.

###### Genome sequencing project information

  -----------------------------------------------------------------------------------
  **MIGS ID**     **Property**                   **Term**
  ------------- ------------------------------ --------------------------------------
  MIGS-31         Finishing quality              Finished

  MIGS-28         Libraries used                 Two Sanger libraries: 8kb pMCL200\
                                               and fosmid pcc1Fos One 454\
                                               pyrosequence standard library

  MIGS-29         Sequencing platforms           ABI3730, 454 GS FLX

  MIGS-31.2       Sequencing coverage            7.67× Sanger; 50.6× pyrosequence

  MIGS-30         Assemblers                     Newbler, Phrap

  MIGS-32         Gene calling method            Prodigal, GenePRIMP

                  INSDC ID                       CP001820

                  Genbank Date of Release        23-November 2009

                  GOLD ID                        Gc01152

                  NCBI project ID                21091

                  Database: IMG-GEBA             2501651195

  MIGS-13         Source material identifier     DSM 2008

                  Project relevance              Tree of Life, GEBA
  -----------------------------------------------------------------------------------

Growth conditions and DNA isolation
-----------------------------------

*V. parvula* strain Te3^T^, DSM 2008, was grown anaerobically in DSMZ medium 104 (modified PYG-Medium, with the addition of lactate and putrescine) at 37°C \[[@r37]\]. DNA was isolated from 1.5-2 g of cell paste using Qiagen Genomic 500 DNA Kit (Qiagen, Hilden, Germany) following the manufacturer's protocol, with cell lysis protocol L as described in Wu *et al*. \[[@r38]\].

Genome sequencing and assembly
------------------------------

The genome was sequenced using a combination of Sanger and 454 sequencing platforms. All general aspects of library construction and sequencing performed at the JGI can be found at <http://www.jgi.doe.gov/>. 454 Pyrosequencing reads were assembled using the Newbler assembler version 1.1.02.15 (Roche). Large Newbler contigs were broken into 1,716 overlapping fragments of 1,000 bp and entered into assembly as pseudo-reads. The sequences were assigned quality scores based on Newbler consensus q-scores with modifications to account for overlap redundancy and to adjust inflated q-scores. A hybrid 454/Sanger assembly was made using the parallel phrap assembler (High Performance Software, LLC). Possible mis-assemblies were corrected with Dupfinisher \[[@r39]\] or transposon bombing of bridging clones (Epicentre Biotechnologies, Madison, WI). Gaps between contigs were closed by editing in Consed, custom primer walk or PCR amplification. A total of 1,082 Sanger finishing reads were produced to close gaps, to resolve repetitive regions, and to raise the quality of the finished sequence. The error rate of the completed genome sequence is less than 1 in 100,000. Together all sequence types provided 51.2 × coverage of the genome. The final assembly contains 16,169 Sanger and 445,271 pyrosequence reads.

Genome annotation
-----------------

Genes were identified using Prodigal \[[@r40]\] as part of the Oak Ridge National Laboratory genome annotation pipeline, followed by a round of manual curation using the JGI GenePRIMP pipeline (<http://geneprimp.jgi-psf.org>) \[[@r41]\]. The predicted CDSs were translated and used to search the National Center for Biotechnology Information (NCBI) nonredundant database, UniProt, TIGRFam, Pfam, PRIAM, KEGG, COG, and InterPro databases. Additional gene prediction analysis and functional annotation were performed within the Integrated Microbial Genomes Expert Review (IMG-ER) platform (<http://img.jgi.doe.gov/er>) \[[@r42]\].

Genome properties
=================

The genome is 2,132,142 bp long and comprises one main circular chromosome with a 38.6% GC content ([Table 3](#t3){ref-type="table"} and [Figure 3](#f3){ref-type="fig"}). Of the 1,920 genes predicted, 1,859 were protein coding genes, and 61 RNAs; 15 pseudogenes were also identified. The majority (73.6%) of the genes were assigned a putative function while those remaining were annotated as hypothetical proteins. The distribution of genes into COGs functional categories is presented in [Table 4](#t4){ref-type="table"}.

###### Genome Statistics

  **Attribute**                      Value       \% of Total
  ---------------------------------- ----------- -------------
  Genome size (bp)                   2,132,142   100.00%
  DNA coding region (bp)             1,886,054   88.46%
  DNA G+C content (bp)               823,631     38.63%
  Number of replicons                1           
  Extrachromosomal elements          0           
  Total genes                        1,920       100.00%
  RNA genes                          61          3.18%
  rRNA operons                       4           
  Protein-coding genes               1,859       96.82%
  Pseudo genes                       15          0.78%
  Genes with function prediction     1,413       73.59%
  Genes in paralog clusters          174         9.06%
  Genes assigned to COGs             1,474       76.77%
  Genes assigned Pfam domains        1,490       77.06%
  Genes with signal peptides         306         15.94%
  Genes with transmembrane helices   492         25.62%
  CRISPR repeats                     5           

![Graphical circular map of the genome. From outside to the center: Genes on forward strand (color by COG categories), Genes on reverse strand (color by COG categories), RNA genes (tRNAs green, rRNAs red, other RNAs black), GC content, GC skew.](sigs.521107-f3){#f3}

###### Number of genes associated with the general COG functional categories

  **Code**   **value**   **%age**     **Description**
  ---------- ----------- ---------- ----------------------------------------------------------------
  J          142         7.6          Translation, ribosomal structure and biogenesis
  A          0           0.0          RNA processing and modification
  K          71          3.8          Transcription
  L          92          4.9          Replication, recombination and repair
  B          2           0.1          Chromatin structure and dynamics
  D          20          1.1          Cell cycle control, mitosis and meiosis
  Y          0           0.0          Nuclear structure
  V          26          1.4          Defense mechanisms
  T          29          1.6          Signal transduction mechanisms
  M          106         5.7          Cell wall/membrane biogenesis
  N          6           0.3          Cell motility
  Z          0           0.0          Cytoskeleton
  W          0           0.0          Extracellular structures
  U          35          1.9          Intracellular trafficking and secretion
  O          48          2.6          Posttranslational modification, protein turnover, chaperones
  C          100         5.4          Energy production and conversion
  G          68          3.6          Carbohydrate transport and metabolism
  E          160         8.6          Amino acid transport and metabolism
  F          63          3.4          Nucleotide transport and metabolism
  H          117         6.3          Coenzyme transport and metabolism
  I          33          1.8          Lipid transport and metabolism
  P          124         6.7          Inorganic ion transport and metabolism
  Q          19          1.8          Secondary metabolites biosynthesis, transport and catabolism
  R          177         9.5          General function prediction only
  S          143         7.7          Function unknown
  \-         385         20.7         Not in COGs
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